32
Participants
Start Date
August 24, 2006
Primary Completion Date
December 12, 2006
Study Completion Date
December 12, 2006
Ropinirole
Subjects will receive ropinirole 0.5 mg for first 7 days, 1 mg from Day 8-14, 2 mg from Day 15-21, 3 mg from Day 22-28, 4 mg from Day 29-35, 5 mg from Day 36-42 and 6 mg from Day 43-51.
GSK Investigational Site, George
GSK Investigational Site, Berlin
Lead Sponsor
GlaxoSmithKline
INDUSTRY